KDL Biotech (Delisted) share news and announcements
BSE: 532291
Formerly Kopran Drugs
Last traded ₹2.14 on 16 Mar 2015
Delisted on 11 May 2018.
KDL Biotech share news and announcements
172 announcements, routine notices left out, newest first. Page 4 of 4.
Aug 2008
18 Aug · Meeting
In accordance with the provisions of Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules 2001. To consider and if thought fit, to pass through Postal Ballot, the following Resolution as a special resolution: Further issues of shares under Section 81 (1A) and Chapter XIII of SEBI (Disclosure and Investor Protection) Guidelines, 2000 on Preferential Basis. The Company has appointed Mr. S.N. Ananthasubramanian a Practicing Company Secretary, as the Scrutinizer for conducting the postal ballot voting process. The duly completed postal ballot form should reach the scrutinizer not later than closing of working hours on August 26, 2008. The Scrutinizer will submit his report, to the Chairman after completion of the scrutiny and the result of the voting by postal ballot will be announced on or before August 27, 2008. A copy of the notice of postal ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Aug · Limited Review Report
Auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.4 Aug · Disclosure
With reference to Clause IV of SEBI (Insider Trading)(Amendment) Regulations 2002, Regulations 13(3) & (6) that Substantial Shareholders (as per attachment) has sold equity shares of KDL Biotech Limited . The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
29 Jul · Public Announcement
Public Announcement ("Public Announcement or "PA" is being issued by Edelweiss Capital Limited (hereinafter referred to as "Manager to the offer" or "Edelweiss"), on behalf of Unimark Remedies Limited (hereinafter referred to as the "Acquirer" or "Unimark") to the equity shareholders ("Shareholders") of KDL Biotech Limited (hereinafter referred to as the "KDL" or "Target Company"), pursuant to and in compliance with, among others Regulations 10 and 12 and as required under the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto ("SEBI (SAST) Regulations 1997").The offer is being made to acquire upto 4,807,030 Shares being 20% of the Expanded Equity Capital which will be total voting Share capital of the Target Company as on October 23, 2008 , being the date which is 15 days from the date of closure of the Offer, as required under Regulation 21(5) of the SEBI (SAST) Regulations. This offer is being made at a price of Rs.12 (Rupees Twelve Only) per Share (the "offer Price") payable in cash and subject to the terms and conditions to be set out in the letter of offer (the "Letter of offer") in relation to the Offer. A schedule of the activities pertaining to the Offer is given below: (1) Specified Date - August 11, 2008. (2) Date of Opening of the offer - September 19, 2008. (3) Date of Closing of the Offer- October 08, 2008. A copy of the public announcement shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jul · Allotment
Board of Directors at their meeting held on July 26, 2008 have approved issue and allotment of 72,72,727 (Seventy Two Lakhs Seventy Two Thousand Seven Hundred and Twenty Seven) equity shares of the Company on a preferential allotment basis to Unimark Remedies Limited at a price of Rs.12/- per equity share. The approval of members will be sought through a postal ballot and Mr. S. N. Anathasubramanian, Practising Company Secretary has been appointed as the Scrutinizer for the postal ballot.22 Jul · Board meeting
To review the financial status of the Company.18 Jul · Management
Board of Directors of the Company at their meeting held on July 18, 2008 have appointed the following persons as an additional Director of the Company w.e.f July 18, 2008: (1) Mr. Sanjay Sinha. (2) Mr. Harish Bhardwaj. (3) Mr. Tushar Kumar Srivastava. (4) Mr Yogendra Kumar Chauhan. Further the Company inform that in the meeting the following Directors have resigned from the Board and same has been accepted by the Board.(1) Mr. Raman Sharma. (2) Mr Hardeep Sachdeva.15 Jul · Board meeting
To discuss routine matter.
May 2008
3 May · Adjournment of meeting
Kdl Biotech Limited had informed the Exchange regarding the Meeting of the Board of Directors of the Company was held on April 30, 2008, to consider inter-alia the Unaudited Financial Results of the Company for the Quarter ended March 31, 2008. The Company has now informed the Exchange that the Unaudited Financial Results of the Company were not placed before the Board and approved by them, as the Accounts were not ready owing to the resignations of the officials who were handling the Accounts. The meeting was adjourned for the above items and it will be held as and when the Unaudited Financial Results would be ready.
Apr 2008
23 Apr · Board meeting
Meeting on 30 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Mar 2008
5 Mar · Meeting
Annual General Meeting of the Company will be held on March 29, 2008. Further the Register of Members and Share Transfer Books of the Company will remain closed from March 26, 2008 to March 29, 2008 (both days inclusive) for the purpose of Annual General Meeting.
Jan 2008
17 Jan · Board meeting
Meeting on 25 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
14 Dec · Board meeting
To transact the following business : 1) To take on record Un-audited Financial Results for the quarter ended 30th September 2007. 2) To take on record Audited Financial Results for the eighteen month Year ended 30th September 2007. 3) Any other matter.14 Dec · Extension
The Company has received permission u/s 166(1) of the Companies Act 1956 for the extension time to hold Annual General Meeting up to 30-03-20083 Dec · Adjournment of meeting
Company could not hold the Board Meeting on December 3, 2007 due to required number of Directors's presence. The Meeting was adjourned for want of quorum; the Company will inform further the exact date of meeting to be held.
Nov 2007
28 Nov · Board meeting
To transact the following business : 1) To take on record Un-audited Financial Results for the quarter ended 30th September 2007. 2) To take on record Audited Financial Results for the eighteen month Year ended 30th September 2007. 3) Any other matter.
Oct 2007
16 Oct · Results
We are required to file the 2nd Qtr results for the period 01.07.07 to 30.09.07 on or before 31.10.07. However, due to shortage of manpower resulted from important key persons leaving the organization, we have decided to extend the financial year ending 31st March 2007 by six months and accordingly, the financial year ending 31st March 2007 was extended upto 30th September 2007, comprising a period of 18 months. We have already obtained ROC approval in this respect. In this line, we will be convening the Shareholders Meeting for approval of Audited Balance Sheet on or before 30th December 2007. We shall be filing 2nd Qtr results for the period 01.07.07 to 30.09.07 on or before 4th December along with audited results for 18 month ended 30.09.2007
Jul 2007
19 Jul · Board meeting
To transact the following business: (1) To take on record Un-Audited Financial Results for the quarter ended June 30, 2007. (2) Any other matter.
May 2007
22 May · Management
Mr. Deepak Malik director has resigned from the board of the company with effect from 14th April, 2007". Further the Company has informed the Exchange that "Mr. Dr. Rajesh Agrawal has been appointed as additional director on the board with effect from 26th April, 2007. The Company has received their consent to act as directors
Apr 2007
19 Apr · Management
Mr.Amit Ravka, Company Secretary and Compliance Officer has left the services of the Company from 15th March, 2007. Please note that with effect from 1st April, 2007 Mr. Sapan Chakraborty, Vice President (Accounts & Commercial) of the Company has been entrusted with additional responsibility of Compliance Officer19 Apr · Board meeting
To transact the following business; (1) to take on record Un-Audited Financial Results for the quarter ended March 31, 2007. (2) to take on record resignation of Director. (3) to approve & appoint the Additional Director. (4) any other matter.
Jan 2007
23 Jan · Board meeting
Meeting on 25 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”